XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash Flows From Operating Activities        
Net loss $ (15,103,722) $ (5,326,724) $ (6,659,899) $ (16,474,688)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization expense 844,091 974,164 1,302,384 3,663,953
Bad debt expense (recovery) (85,535) 175,463 (143,774) 492,906
Impairment expense 24,881 0 0 4,420,539
Loss on shares issued in settlement of consulting agreement 152,629 0    
Loss or (gain) on debt settlement 8,521,149 (178,749) 0 (1,205,195)
Equity based compensation expense 5,076,167 1,106,460 1,490,903 4,106,040
Loss on fair value of marketable securities 246,532 0 170,383 42,270
(Gain) on assets sale (1,763,430) 0    
Warrant modification expense     0 152,244
Change in fair value of warrant liability (72,755) 0 (96,000) 0
Amortization of debt discount and debt costs 177,072 1,212,006 1,346,280 499,031
Loss on loan amendment     (193,355)  
Factoring discount fee and interest   20,480 22,009 179,303
Change in fair value of earn-out liability     0 26,604
Gain on sale of intangible assets     0 (250,000)
Changes in assets and liabilities:        
Decrease (increase) in accounts receivable 451,844 (99,801) 1,967,824 (1,492,093)
Increase (decrease) in prepaid expenses and other current assets 99,101 (684) 95,623 253,149
Increase in accounts payable and accrued liabilities (230,885) 277,632 (18,489) (594,967)
Investment in Marketable Securities     (382,144) 0
Decrease in accounts receivable - related parties     0 49,033
Decrease in accounts payable and accrued liabilities - related parties     0 (163,672)
(Decrease) increase in deferred revenue (44,431) (32,696) (65,371) (531,231)
Net cash (used) in operating activities (1,707,292) (1,872,449) (947,299) (6,948,288)
Cash Flows From Investing Activities:        
Proceeds from sale of assets 1,763,430      
Capitalized software development costs     0 (1,325,491)
Proceeds from sale of intangible assets     0 1,050,000
Purchase of property and equipment     0 (74,606)
Net cash provided by investing activities 1,763,430   0 (350,097)
Cash Flows From Financing Activities:        
Repayment of ERC advances 0 (450,000) (450,000) 0
Proceeds from notes     0 4,077,127
Proceeds from ERC advances 0 450,000 450,000 0
Deferred payroll taxes     0 (79,244)
Issuance of common stock, net of fees 2,230,975 785,509    
Payments of promissory notes (592,057)      
Repayments of notes (1,071,552) (495,473) (668,478) (2,013,661)
Proceeds from factoring agreement   871,821 871,821 7,303,537
Repayments of factoring agreement   (175,127) (215,127) (3,705,876)
Purchase of preferred shares pursuant to recapitalization   (80,000)    
Gross proceeds from exercise of warrants 592,057 315,178 315,178 0
Issuance of common stock, net of equity issuance costs of $280,490     (785,509)  
Purchase of preferred shares pursuant to recapitalization     (80,000)  
Net cash provided by financing activities 1,159,423 1,221,908 1,008,903 5,661,127
Net increase (decrease) in cash 1,215,561 (650,541) 61,604 (1,637,258)
Cash, beginning of period 1,008,408 946,804 946,804 2,584,062
Cash, end of period 2,223,969 296,263 1,008,408 946,804
Supplemental disclosures of cash flow information:        
Cash paid during the period for interest 150,461 256,552 323,141 256,648
Cash paid during the period for income taxes     0 0
Supplemental schedule of non-cash investing and financing activities:        
Issuance of common stock issued upon conversion of note payable 273,673      
Issuance of common stock upon exercise of warrants and conversion of debt 1,115,437      
Issuance of common stock from conversion of Preferred stock, Series E 9      
Warrants issued in connection with purchase of intangible assets 480,358      
Issuance of common stock for debt settlements 11,029,647      
Issuance of common stock issued upon purchase of intangible assets 647,055      
Offering costs as a result of modification of warrants to induce exercise   10,400    
Debt issuance costs accrued   50,000 50,000 0
Debt discount on warrants granted with notes   600,000    
Accounts receivable owed under factoring agreement collected directly by factor   1,000,020 959,980 3,495,683
Purchase price measurement period adjustment to goodwill and accounts receivable     0 $ 35,644
Common shares issued to settle accrued liability       409,036
Debt discount on warrants granted with notes     0 $ 1,632,842
Deemed dividends $ 0 $ (503,643) (503,642) (1,921,213)
Offering costs as a result of modification of warrants to induce exercise     10,400 0
Financing of insurance premium     92,174 0
Debt Discount on loan amendment     50,000 0
Transfer of accrued interest to loan principal upon loan amendment     $ 80,555 $ 0